Schroder Investment Management Group
MEDP icon

Schroder Investment Management Group’s Medpace MEDP Stock Holding History

Schroder Investment Management Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.99M Sell
7,468
-11
-0.1% -$5.08K ﹤0.01% 819
2026
Q1 		$3.44M Buy
7,479
+3,258
+77% +$1.67M ﹤0.01% 838
2025
Q4 		$2.4M Buy
4,221
+2,969
+237% +$1.69M ﹤0.01% 863
2025
Q3 		$627K Buy
+1,252
New +$547K ﹤0.01% 1067
2025
Q1 		– Sell
-3,536
Closed -$1.18M – 1242
2024
Q4 		$1.18M Sell
3,536
-63,731
-95% -$21.6M ﹤0.01% 996
2024
Q3 		$22.3M Sell
67,267
-22,286
-25% -$8.47M 0.02% 487
2024
Q2 		$36.9M Buy
89,553
+15,280
+21% +$6.05M 0.04% 340
2024
Q1 		$30M Sell
74,273
-23,511
-24% -$8.27M 0.04% 399
2023
Q4 		$30M Sell
97,784
-7,965
-8% -$2.15M 0.04% 392
2023
Q3 		$25.6M Buy
105,749
+4,802
+5% +$1.23M 0.04% 399
2023
Q2 		$24.2M Buy
100,947
+54,570
+118% +$11.3M 0.03% 430
2023
Q1 		$8.72M Buy
46,377
+20,231
+77% +$4.18M 0.01% 653
2022
Q4 		$5.55M Buy
26,146
+871
+3% +$174K 0.01% 761
2022
Q3 		$3.97M Sell
25,275
-956
-4% -$153K 0.01% 818
2022
Q2 		$3.93M Sell
26,231
-22,144
-46% -$3.21M 0.01% 843
2022
Q1 		$7.91M Sell
48,375
-20,123
-29% -$3.32M 0.01% 727
2021
Q4 		$14.9M Buy
68,498
+23,885
+54% +$5M 0.02% 535
2021
Q3 		$8.44M Sell
44,613
-22,979
-34% -$4.19M 0.01% 669
2021
Q2 		$11.9M Sell
67,592
-4,547
-6% -$785K 0.02% 625
2021
Q1 		$11.8M Buy
72,139
+23,654
+49% +$3.62M 0.02% 620
2020
Q4 		$6.75M Sell
48,485
-52,627
-52% -$6.63M 0.01% 734
2020
Q3 		$11.6M Buy
101,112
+34,868
+53% +$4.03M 0.02% 553
2020
Q2 		$6.16M Buy
+66,244
New +$5.64M 0.01% 648
2019
Q4 		– Sell
-3,763
Closed -$313K – 1321
2019
Q3 		$313K Sell
3,763
-4,017
-52% -$304K ﹤0.01% 1111
2019
Q2 		$508K Buy
+7,780
New +$448K ﹤0.01% 1075

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Schroder Investment Management Group's MEDP Position: Q2 2026 in Review

Schroder Investment Management Group reduced its Medpace (MEDP) stake by 0.15% in Q2 2026, selling an estimated $5.08K and leaving 7,468 shares worth $3.99M. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Schroder Investment Management Group first reported a position in MEDP in Q2 2019 and has held it in 25 quarters since. The position peaked at $36.9M in Q2 2024. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Schroder Investment Management Group held 7,468 shares of Medpace worth $3.99M as of Q2 2026.
  • Schroder Investment Management Group sold 11 Medpace shares in Q2 2026, an estimated $5.08K.
  • Medpace made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #819 holding.
  • Schroder Investment Management Group first reported a position in Medpace in Q2 2019 and has held it in 25 quarters since.
  • Schroder Investment Management Group's Medpace position peaked at $36.9M in Q2 2024.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.